DOCSLIB.ORG

Name of Presentation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Name of Presentation 3/21/2018 Outcomes Newborn Assessment • Understand newborn history • Discuss APGAR scoring Dr. Susan Ward PhD, RN, LCCE • Discuss newborn vital signs, weight and Lee Ann Caracciolo RN measurement • Examine newborn medications • Explore newborn assessment • Practice newborn assessment test questions History History Antepartum/OB Intrapartum • Para/gravida • Maternal age • Prenatal care • Prenatal care • Spontaneous/induction • Previous preterm • Pre-existing medical births/complications • Medications conditions such as • Medications - Rx, • Membranes ruptured? infertility, chronic illicit, over-the- • Meconium stained? counter, tobacco or hypertension… • alcohol use • High risk factors such Type of delivery • EDC as GDM, clotting or • Apgar scores seizure disorders • Antenatal testing Apgar Scoring (not predictive of neonatal mortality or morbidity) • Performed at 1 and 5 minutes of age • If the Apgar score is less than 7 at 5 minutes of age, the Neonatal Resuscitation Program guidelines state that the assessment should be repeated every 5 minutes for up to 20 minutes • Reflects status of infant and response to resuscitation 1 3/21/2018 Newborn Vital Signs (37to 41 weeks) Other assessment questions Vital Signs • Temperature - is the baby overwrapped, just • Temperature finished nursing or was he snuggling with • Normal axillary is 97.7-99.3 degrees F • Heart Rate mom? • Normal range 100-160 beats per • HR- is the baby awake? HR can decrease to 70 minute bpm while sleeping. Does the HR increase • Respiratory Rate with stimulation? • Normal range 30-60 beats per minute • RR - what is the baby’s color? and non-labored *Count HR and RR for one full minute Weight and Measurement Medications • Use a growth chart to determine SGA, AGA, LGA Vitamin K (phytonadione) • Weight (average 3405 gm or 7 lbs 8 oz) • Every newborn receives a single parenteral dose (IM) of natural Vitamin K1 (phytonadione) 0.5 to 1 mg • Less than 2748 grams (6 lbs) small for gestational age or preterm, greater than 4050 grams (9 lbs) large for gestational • Prophylaxis and treatment of Vitamin K deficiency age or infants of diabetic mothers bleeding (VKDB) • Coagulation factors (II, VII, IX, & X) formed in the • Chest circumference • Measure at level of nipples after exhalation liver • 30-35 cm (12-14 inches) • Requires Vitamin K for final synthesizes. • Sterile intestinal flora does not allow for Vitamin K • Head circumference • Measure just above eyebrows and around to occipital synthesis prominence in back of skull • Administer shortly after birth • 32 to 37 cm (12.5 to 14.5 inches) • Oral administration has not shown to be as effective • Length for prevention of late hemorrhagic disease • Measure top to head to heel • 48 to 52 cm (18 to 22 inches) Hepatitis B Vaccination Eye Prophylaxis • Hepatitis B is a contagious liver disease caused by the hepatitis B virus • Erythromycin 0.5% ointment is the most effective prophylaxis medication for vaginal and cesarean • All medical stable babies receive the first vaccine of hepatitis B deliveries against Gonococcal Ophthlamia vaccine before they leave the hospital Neonatorum and Chlamydia • The vaccine acts as a protectant, reducing the newborn’s risk of • Administration of eye prophylaxis is required in all acquiring the disease from the mother or family members who states may not know they are infected with Hepatitis B Virus • The administration of the ointment may be delayed • B Vaccine (Engerix-B, Recombivax HB) - the 1st dose of 10 mcg is until after initial breastfeeding in the delivery room given IM in vastus lateralis • The eye ointment should reach all parts of the • Hepatitis B Immuno-globulin (HBIG) - 0.5ml given IM if the conjunctival sac. After one minute the excess mother’s HBsAg status is positive or unknown, within 12 hours of medication can be wiped away with a sterile cotton birth swab or gauze AAP & ACOG (2012, p. 295) 2 3/21/2018 Techniques of Physical Assessment Newborn Assessment Assessment Skills Basic Principles • Observation • First hours of life • Auscultation • Subtle signs/symptom(s) – one • Palpation sign or a combination of • Percussion signs • Translumination • Review history for (scrotal sac) potential clues • Quiet environment • Calm and warm infant Physical Assessment Skin Assessment • Head to toe assessment – Count umbilical vessels Skin Color and Variations • Two arteries, one vein • Pink, warm and dry are the standard indicators that • Report a two vessel cord verify a newborn’s overall health status – Apgar scoring – Vital signs • All healthy newborns have a pink tinge to their skin – Weight and measurements – Medications • The pigment, melanin, is passed on to a newborn by – Skin his/her parents and determines skin tone, which can – Head and neck darken overtime based on genetic disposition – Respiratory system – Cardiovascular system • Ruddy skin color is due to the increased red blood cell – Abdomen concentration in the blood vessels and limited – Musculoskeletal system subcutaneous fat deposits (plethora) – Genitourinary system – Neurologic system Acrocyanosis (bluish color of hands and feet and might be present in first 24 hours of life) Skin Assessments and Variations • Assess for meconium staining • Inspect the newborn’s back for a closed vertebral column and for any abnormalities (closed” spina bifida or called Spina Bifida Occulta - causes no problems) • Dimpling Circumoral Cyanosis (cyanosis around the mouth) • Tuft of hair • Masses • Assess turgor (hydration status) • Skin should be elastic and should return rapidly to its original shape 3 3/21/2018 Vernix Caseosa Lanugo • Fine “downy” hair • A protective layer or covering (in utero it protects the • Part of gestational age assessment newborn that is surrounded by amniotic fluid) • At term, Lanugo is only present on shoulders, forehead and pinna of • Cheese-like, thick, whitish, substance fused to epidermis ears • Vernix Caseosa is visible in the skin folds, creases, • Lanugo in Postmature newborns axillary and genital areas is absent • Lanugo in Premature newborns • The actual amount found is effected by gestational age is long and thick on the back • Note the color – green (meconium stained), yellow (Rh and/or shoulders blood incompatibility), foul smell may indicate intrauterine infection that could be passed on to the newborn Mottling Skin Color and Variations • Cutis Marmorata or Skin Mottling is a “lacy pattern” on the skin and occurs as a result of general circulation Jaundice (physiological or Icterus fluctuations. It can last several hours to several weeks. Neonatorum) results from the accumulation Mottling may also be related to chilling, prolonged apnea, sepsis or hypothyroidism of bile pigments and associated with an • Capillary refill is > 3 seconds is abnormal – provides excessive amount of bilirubin in the blood. Is information about the infant’s cardiac perfusion worsened by ecchymosis – forcep marks, severe caput, cephalohematomas, bruising due to trauma. Seen in 30-50% of all normal term newborns Skin Color and Variations Skin Color and Variations • Hyperbilirubinemia • Administer phototherapy (the level of bilirubin determines if – Occurs within the first 24 hours of life the newborn is placed under single, double or triple – The Total Serum Bilirubin (TSB) increases by 0.5 mg/dL per phototherapy). Side effects of phototherapy are loose hour or 5mg/dL per day watery stools, diaper rash and dehydration – The diagnosis is made when the TSB concentrations climb ≥ • Fiber optic systems (Bili Blanket) can also deliver 12.9 mg/dL in a term infant and ≥ 15/mg/dL in a preterm phototherapy in a blanket form placed under or around the infant newborn – Visual observation is first noticed in the head and gradually • During phototherapy cover the newborn’s eyes and genital progresses to the thorax, abdomen and extremities area to prevent retinal and tissue damage. Remove the mask during feedings and shut off the lights – Use the Transcutaneous bilirubinometry (TcB) which is non invasive way to get a more accurate then visual reading of • Monitor the newborn’s temperature closely for hypothermia the infant’s bilirubin level • Excess bilirubin is excreted through the stools 4 3/21/2018 Mongolian Spot Harelequin Sign (Congenital Dermal Melanocytosis) Difference in color of half of the face or body (Harlequin’s sign) generally related to immature hypothalamic center The most common pigmented lesion in newborns Flushing occurs on dependent side (this Mistaken for a bruise due to newborn was placed on right side before gray/green color the current supine position) Location is the buttocks, flanks, or shoulders May fade over time Milia - raised white Epstein Pearls - Forcep Mark spots on the face and whitish-yellow cysts nose that form on the gums • Pressure marks are typically red or and roof of the mouth bruised areas from the use of forcep on the face, scalp, and/or cheeks • Examine the infant thoroughly or note other complications such as skull fracture, fractured clavicle, facial palsy Bohn’s Nodules - grayish white lesions in this newborn's mouth that resolve spontaneously Accessory Nipple(s) Erythema Toxicum Neonatorum • Accessory or supernumerary nipple(s) can be single or Newborn rash (cause unknown) –a multiple, flat, tan or brown spots along the “milk line” below and medial to the true nipple(s) pale yellow colored papule or pustules that vary in size from 1 to 3 • Often darken at puberty millimeters • Diagnosed when dimpling occurs when adjacent skin is stretched away from the nipple(s) Most commonly
Load more

Recommended publications
  • Routine Administration of Vitamin K1 Prophylaxis to the Newborn
    Routine Administration of Vitamin K1 Prophylaxis to the Newborn Practice Resource for Health Care Providers July 2016 Practice Resource Guide: ROUTINE ADMINISTRATION OF VITAMIN K1 PROPHYLAXIS TO THE NEWBORN The information attached is the summary of the position statement and the recommendations from the recent CPS evidence-based guideline for routine intramuscular administration of Vitamin K1 prophylaxis to the newborn*: www.cps.ca/documents/position/administration-vitamin-K-newborns Summary Vitamin K deficiency bleeding or VKDB (formerly known as hemorrhagic disease of the newborn or HDNB) is significant bleeding which results from the newborn’s inability to sufficiently activate vitamin K-dependent coagulation factors because of a relative endogenous and exogenous deficiency of vitamin K.1 There are three types of VKDB: 1. Early onset VKDB, which appears within the first 24 hours of life, is associated with maternal medications that interfere with vitamin K metabolism. These include some anticonvulsants, cephalosporins, tuberculostatics and anticoagulants. 2. Classic VKDB appears within the first week of life, but is rarely seen after the administration of vitamin K. 3. Late VKDB appears within three to eight weeks of age and is associated with inadequate intake of vitamin K (exclusive breastfeeding without vitamin K prophylaxis) or malabsorption. The incidence of late VKDB has increased in countries that implemented oral vitamin K rather than intramuscular administration. There are three methods of Vitamin K1 administration: intramuscular, oral and intravenous. The Canadian Paediatric Society (2016)2 and the American Academy of Pediatrics (2009)3 recommend the intramuscular route of vitamin K administration. The intramuscular route of Vitamin K1 has been the preferred method in North America due to its efficacy and high compliance rate.
    [Show full text]
  • Extrinsic Factors Influencing Fetal Deformations and Intrauterine
    Hindawi Publishing Corporation Journal of Pregnancy Volume 2012, Article ID 750485, 11 pages doi:10.1155/2012/750485 Review Article Extrinsic Factors Influencing Fetal Deformations and Intrauterine Growth Restriction Wendy Moh, 1 John M. Graham Jr.,2 Isha Wadhawan,2 and Pedro A. Sanchez-Lara1 1 Center for Craniofacial Molecular Biology, Ostrow School of Dentistry and Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, 4650 Sunset Boulevard, MS 90, Los Angeles, CA 90027, USA 2 Cedars-Sinai Medical Center, Medical Genetics Institute and David Geffen School of Medicine at UCLA, 8700 Beverly Boulevard, PACT Suite 400, Los Angeles, CA 90048, USA Correspondence should be addressed to Pedro A. Sanchez-Lara, [email protected] Received 24 March 2012; Revised 4 June 2012; Accepted 4 June 2012 Academic Editor: Sinuhe Hahn Copyright © 2012 Wendy Moh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The causes of intrauterine growth restriction (IUGR) are multifactorial with both intrinsic and extrinsic influences. While many studies focus on the intrinsic pathological causes, the possible long-term consequences resulting from extrinsic intrauterine physiological constraints merit additional consideration and further investigation. Infants with IUGR can exhibit early symmetric or late asymmetric growth abnormality patterns depending on the fetal stage of development, of which the latter is most common occurring in 70–80% of growth-restricted infants. Deformation is the consequence of extrinsic biomechanical factors interfering with normal growth, functioning, or positioning of the fetus in utero, typically arising during late gestation.
    [Show full text]
  • Neonatal Orthopaedics
    NEONATAL ORTHOPAEDICS NEONATAL ORTHOPAEDICS Second Edition N De Mazumder MBBS MS Ex-Professor and Head Department of Orthopaedics Ramakrishna Mission Seva Pratishthan Vivekananda Institute of Medical Sciences Kolkata, West Bengal, India Visiting Surgeon Department of Orthopaedics Chittaranjan Sishu Sadan Kolkata, West Bengal, India Ex-President West Bengal Orthopaedic Association (A Chapter of Indian Orthopaedic Association) Kolkata, West Bengal, India Consultant Orthopaedic Surgeon Park Children’s Centre Kolkata, West Bengal, India Foreword AK Das ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama (021)66485438 66485457 www.ketabpezeshki.com ® Jaypee Brothers Medical Publishers (P) Ltd. Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. Jaypee Brothers Medical Publishers Ltd. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton The Bourse SW1H 0HW (UK) Panama City, Panama 111, South Independence Mall East Phone: +44-2031708910 Phone: +507-301-0496 Suite 835, Philadelphia, PA 19106, USA Fax: +02-03-0086180 Fax: +507-301-0499 Phone: +267-519-9789 Email: [email protected] Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd. Jaypee Brothers Medical Publishers (P) Ltd. 17/1-B, Babar Road, Block-B, Shaymali Shorakhute, Kathmandu Mohammadpur, Dhaka-1207 Nepal Bangladesh Phone: +00977-9841528578 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher.
    [Show full text]
  • Vitamin K for the Prevention of Vitamin K Deficiency Bleeding (VKDB)
    Title: Vitamin K for the Prevention of Vitamin K Deficiency Bleeding (VKDB) in Newborns Approval Date: Pages: NEONATAL CLINICAL February 2018 1 of 3 Approved by: Supercedes: PRACTICE GUIDELINE Neonatal Patient Care Teams, HSC & SBH SBH #98 Women’s Health Maternal/Newborn Committee Child Health Standards Committee 1.0 PURPOSE 1.1 To ensure all newborns are properly screened for the appropriate Vitamin K dose and route of administration and managed accordingly. Note: All recommendations are approximate guidelines only and practitioners must take in to account individual patient characteristics and situation. Concerns regarding appropriate treatment must be discussed with the attending neonatologist. 2.0 PRACTICE OUTCOME 2.1 To reduce the risk of Vitamin K deficiency bleeding. 3.0 DEFINITIONS 3.1 Vitamin K deficiency bleeding (VKDB) of the newborn: previously referred to as hemorrhagic disease of the newborn. It is unexpected and potentially severe bleeding occurring within the first week of life. Late onset VKDB can also occur in infants 2-12 weeks of age with severe vitamin k deficiency. Bleeding in both types is primarily gastro-intestinal and intracranial. 3.2 Vitamin K1: also known as phytonadione, an important cofactor in the synthesis of blood coagulation factors II, VII, IX and X. 4.0 GUIDELINES Infants greater than 1500 gm birthweight 4.1 Administer Vitamin K 1 mg IM as a single dose within 6 hours of birth. 4.1.1 The infant’s primary health care provider (PHCP): offer all parents the administration of vitamin K intramuscularly (IM) for their infant. 4.1.2 If parent(s) refuse any vitamin K administration to the infant, discuss the risks of no vitamin K administration, regardless of route, with the parent(s).
    [Show full text]
  • SUBGALEAL HEMATOMA Sarah Meyers MS4 Ilse Castro-Aragon MD CASE HISTORY
    SUBGALEAL HEMATOMA Sarah Meyers MS4 Ilse Castro-Aragon MD CASE HISTORY Ex-FT (37w6d) male infant born by low transverse C-section for arrest of descent and chorioamnionitis to a 34-year-old G2P1 mother. The infant had 1- and 5-minute APGAR scores of 9 and 9, weighed 3.625 kg (54th %ile), and had a head circumference of 34.5 cm (30th %ile). Following a challenging delivery of the head during C/s, the infant was noted to have left-sided parietal and occipital bogginess, and an ultrasound was ordered due to concern for subgaleal hematoma. PEDIATRIC HEAD ULTRASOUND: SUBGALEAL HEMATOMA Superficial pediatric head ultrasound showing moderately echogenic fluid collection (green arrow), superficial to the periosteum (blue arrow), crossing the sagittal suture (red arrow). Findings on U/S consistent with large parieto-occipital subgaleal hematoma. PEDIATRIC HEAD ULTRASOUND: SUBGALEAL HEMATOMA Superficial pediatric head ultrasound showing moderately echogenic fluid collection (green arrow), consistent with large parieto-occipital subgaleal hematoma. CLINICAL FOLLOW UP - Subgaleal hematoma was confirmed on ultrasound and the infant was transferred from the newborn nursery to the NICU for close monitoring, including hourly head circumferences and repeat hematocrit measurements - Serial head circumferences remained stable around 34 cm and hematocrit remained stable between 39 and 41 throughout hospital course - The infant was subsequently treated with phototherapy for hyperbilirubinemia, thought to be secondary to resorption of the SGH IN A NUTSHELL:
    [Show full text]
  • Acne in Childhood: an Update Wendy Kim, DO; and Anthony J
    FEATURE Acne in Childhood: An Update Wendy Kim, DO; and Anthony J. Mancini, MD cne is the most common chron- ic skin disease affecting chil- A dren and adolescents, with an 85% prevalence rate among those aged 12 to 24 years.1 However, recent data suggest a younger age of onset is com- mon and that teenagers only comprise 36.5% of patients with acne.2,3 This ar- ticle provides an overview of acne, its pathophysiology, and contemporary classification; reviews treatment op- tions; and reviews recently published algorithms for treating acne of differing levels of severity. Acne can be classified based on le- sion type (morphology) and the age All images courtesy of Anthony J. Mancini, MD. group affected.4 The contemporary Figure 1. Comedonal acne. This patient has numerous closed comedones (ie, “whiteheads”). classification of acne based on sev- eral recent reviews is addressed below. Acne lesions (see Table 1, page 419) can be divided into noninflammatory lesions (open and closed comedones, see Figure 1) and inflammatory lesions (papules, pustules, and nodules, see Figure 2). The comedone begins with Wendy Kim, DO, is Assistant Professor of In- ternal Medicine and Pediatrics, Division of Der- matology, Loyola University Medical Center, Chicago. Anthony J. Mancini, MD, is Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children’s Hospital of Chi- cago. Address correspondence to: Anthony J. Man- Figure 2. Moderate mixed acne. In this patient, a combination of closed comedones, inflammatory pap- ules, and pustules can be seen. cini, MD, Division of Dermatology Box #107, Ann and Robert H.
    [Show full text]
  • Prevalence and Characterization of Neonatal Skin Disorders in the First
    J Pediatr (Rio J). 2017;93(3):238---245 www.jped.com.br ORIGINAL ARTICLE Prevalence and characterization of neonatal skin ଝ,ଝଝ disorders in the first 72 h of life a,∗ b b Flávia Pereira Reginatto , Damie DeVilla , Fernanda M. Muller , c c b a,c Juliano Peruzzo , Letícia P. Peres , Raquel B. Steglich , Tania F. Cestari a Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pós-graduac¸ão em Saúde da Crianc¸a e Adolescente, Porto Alegre, RS, Brazil b Complexo Hospitalar Santa Casa de Porto Alegre, Departamento de Dermatologia, Porto Alegre, RS, Brazil c Universidade Federal do Rio Grande do Sul (UFRGS), Hospital de Clínicas de Porto Alegre (HCPA), Departamento de Dermatologia, Porto Alegre, RS, Brazil Received 9 May 2016; accepted 16 June 2016 Available online 19 November 2016 KEYWORDS Abstract Newborn; Objective: To determine the prevalence of neonatal dermatological findings and analyze Neonatology; whether there is an association between these findings and neonatal and pregnancy charac- teristics and seasonality. Child health services; Methods: Newborns from three maternity hospitals in a Brazilian capital city were randomly Child health; selected to undergo dermatological assessment by dermatologists. Infant care; Results: 2938 neonates aged up to three days of life were randomly selected, of whom 309 Skin manifestations were excluded due to Intensive Care Unit admission. Of the 2530 assessed neonates, 49.6% were Caucasians, 50.5% were males, 57.6% were born by vaginal delivery, and 92.5% of the moth- ers received prenatal care. Some dermatological finding was observed in 95.8% of neonates; of these, 88.6% had transient neonatal skin conditions, 42.6% had congenital birthmarks, 26.8% had some benign neonatal pustulosis, 2% had lesions secondary to trauma (including scratches), 0.5% had skin malformations, and 0.1% had an infectious disease.
    [Show full text]
  • Epidemiological Aspects of Neonatal Jaundice and Its Relationship with Demographic Characteristics in the Neonates Hospitalized in Government Hospitals in Ilam, 2013
    Original article J Bas Res Med Sci 2014; 1(2):48-52. Epidemiological aspects of neonatal jaundice and its relationship with demographic characteristics in the neonates hospitalized in government hospitals in Ilam, 2013 Ashraf Direkvand-Moghadam 1, Ali Delpisheh 2, Mosayeb Mozafari *3, Azadeh Direkvand-Moghadam 4, Parvaneh Karzani 4, Parvin Saraee 4, Zahra Safaripour 4, Nasim Mir-Moghadam 4, Mrjan Teimour Pour4 1. Prevention of Psychosocial Injuries Research Center; Department of Midwifery, Ilam University of Medical Sciences, Ilam, Iran 2. Department of Clinical Epidemiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran 3. Department of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran 4. Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran * Corresponding author: Tel: +98 8412227123; fax: +98 8412227123 Address: Dept of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran E-mail: [email protected] Receive d 21/7/2014; revised 28/7/2014; accepted 2/8/2014 Abstract Introduction: Jaundice is one of the hospitalization causes in term and preterm infants. Considering to the side effects of jaundice, the present study aimed to investigate the prevalence and risk factors associated with jaundice in neonates hospitalized in government hospitals in Ilam. Materials and methods: In a case - control study, 384 neonates were enrolled. All neonates hospitalized in Mustafa Khomeini and Imam Khomeini hospital were enrolled in the study. Neonates’ deaths due other causes were excluded from the study. Data collected through a questionnaire. The validity of the questionnaire was determined using content validity and its reliability was determined 84% using Cronbach's alpha coefficient.
    [Show full text]
  • MNCY SCN Postpartum Newborn Pathway
    Alberta Pregnancy Pathways Adopted from Perinatal Services BC, 2015. While every attempt has been made to ensure that the information contained herein is clinically accurate and current, AHS acknowledges that many issues remain controversial, and, therefore, may be subject to practice interpretation. Developed by the Maternal Newborn Child & Youth Strategic Clinical Network™ – Version 4.2 September 2020 Revision Control Version Revision Date Summary of Revisions Author V-1.0 September 2016 Original Document MNCY SCN™ Postpartum Newborn Working Group V-2.0 April 2017 Refer to Summary of Revisions – separate document Ursula Szulczewski, Manager, MNCY SCN™ V-2.1 September 2017 Revisions based on provincial chart audit and staff evaluation Debbie Leitch, Executive Director, MNCY SCNTM V-2.2 March 2018 Revisions to pathway forms Debbie Leitch, Executive Director, MNCY SCNTM Clarification around sedation score and assessment criteria for intrapsinal and intrathecal blocks and epidurals. V-3.0 September 2018 Addition to initial newborn assessment completion guide – Debbie Leitch, Executive Director, MNCY SCNTM assessment of newborn palette to include palpation and visualization. V-3.1 October 2018 Clarification of assessment for motor block. Debbie Leitch, Executive Director, MNCY SCNTM Addition of safe swaddling to comfort or soothe and link to V-4.0 January 2019 Healthy Families, Healthy Children video. Debbie Leitch, Executive Director, MNCY SCNTM Addition of supplementation volumes for breast fed infants. Pg 86 Supplementation volumes to refer to term babies only (not late preterm). Pg 90 Formula volume (for baby not breastfeeding) returned to previous 30ml/kg/24 hours – follow hunger cues. TM V-4.1 March 2019 Pg 108 Newborn stools 48-72 hours: 3 or more transitional Debbie Leitch, Executive Director, MNCY SCN stools/day; 72 hours – 4-6 weeks: 3 or more stools/day Pg 104 Lab bilirubin or transcutaneous bilirubin measured on all infants within 24 hours of birth and prior to discharge.
    [Show full text]
  • Vitamin K Information for Parents-To-Be
    Vitamin K Information for parents-to-be Maternity This leaflet has been written to help you decide whether your baby should receive a vitamin K supplement at birth. What is vitamin K? Vitamin K is needed for the normal clotting of blood and is naturally made in the bowel. page 2 Why is vitamin K given to newborn babies? All babies are born with low levels of vitamin K. Several days after birth, a baby will normally produce their own supply of vitamin K from natural bacteria found in their bowel. They can also get a small amount of vitamin K from their mother’s breast milk and it is added to formula milk. This can help the natural bacteria in the baby’s bowel to develop, which in turn improves their levels of vitamin K. However, babies are more at risk of developing vitamin K deficiency until they are feeding well. A deficiency in vitamin K is the main cause of vitamin K deficiency bleeding (VKDB). This can cause bleeding from the belly button, nose, surgical sites (i.e. following circumcision), and (rarely) in the brain. The risk of this happening is approximately 1 in 100,000 for full term babies. VKDB is a serious disorder, which may lead to internal bleeding. Signs of internal bleeding are: • blood in the nappy • oozing (bleeding) from the cord • nose bleeds • bleeding from scratches which doesn’t stop on its own • bruising • prolonged jaundice (yellowing of the skin) at three weeks if breast feeding and two weeks if formula feeding. VKDB can also lead to bleeding on the brain, which can cause brain damage and/or death.
    [Show full text]
  • Vitamin K for Newborn Babies: Information for Parents
    Vitamin K for Newborn Babies Information for parents This leaflet explains what vitamin K is, and its importance in preventing bleeding problems in newborn babies. We hope it gives you enough information to help you make an informed choice about this part of your baby’s care. What is vitamin K? Vitamin K occurs naturally in food (especially red meat and some green vegetables). It is also produced by friendly bacteria in our gut. We all need it as it helps to make our blood clot and to prevent bleeding problems. Newborn babies and young infants have very little vitamin K. How do low levels of Vitamin K affect a newborn baby? A very small number of babies suffer bleeding problems due to a shortage of vitamin K. This is called Vitamin K Deficiency Bleeding (or VKDB for short). The classical form usually happens in the first week of life. The baby may bleed from the mouth or nose or from the stump of the umbilical cord. Late onset VKDB is a more serious problem which happens after the baby is about three weeks old. The bleeding is sometimes into the gut or the brain and in some cases it can cause brain damage or even death. How can Vitamin K Deficient Bleeding be prevented? The Scottish Government recommends that all newborn babies are given vitamin K to reduce the chances of dangerous internal bleeding. The most effective treatment is a single dose of vitamin K injected into the thigh muscle shortly after birth. Vitamin K by mouth is also effective in most cases but your baby will need to have a number of doses through the first 1-3 months of life.
    [Show full text]
  • Hyperemesis Gravidarum: Strategies to Improve Outcomes
    The Art and Science of Infusion Nursing Hyperemesis Gravidarum Strategies to Improve Outcomes 03/11/2020 on //7dIgeiLuhMkL9kWvKwgfAPGFMPj02nltGDDFVobkWqncHWQRlSg9yjBWU9jBuwQSAQCN6yy/R8eEgzReezmPfm5ALSU3NvEsywdL7iOhefmPs35WVNSjdaQz7H5GI7 by http://journals.lww.com/journalofinfusionnursing from Downloaded Downloaded Kimber Wakefield MacGibbon, BSN, RN from http://journals.lww.com/journalofinfusionnursing ABSTRACT Hyperemesis gravidarum (HG) is a debilitating and potentially life-threatening pregnancy disease marked by weight loss, malnutrition, and dehydration attributed to unrelenting nausea and/or vomiting; HG increases the risk of adverse outcomes for the mother and child(ren). The complexity of HG affects every aspect of a woman’s life during and after pregnancy. Without methodical intervention by knowledgeable and proactive clinicians, life-threatening complications may develop. Effectively managing HG requires an understanding of both physical and psychosocial by //7dIgeiLuhMkL9kWvKwgfAPGFMPj02nltGDDFVobkWqncHWQRlSg9yjBWU9jBuwQSAQCN6yy/R8eEgzReezmPfm5ALSU3NvEsywdL7iOhefmPs35WVNSjdaQz7H5GI7 stressors, recognition of potential risks and complications, and proactive assessment and treatment strategies using innovative clinical tools. Key words: antiemetic, enteral nutrition, genetics, granisetron, HELP score, hyperemesis gravidarum, intravenous, malnutrition, nausea, neurodevelopmental disorder, ondansetron, parenteral nutrition, pregnancy, premature delivery, total parenteral nutrition, vomiting, vomiting center, Wernicke’s encephalopathy,
    [Show full text]